| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $741 | -63.8% |
| R&D Expense | $245K | -52.3% |
| SG&A Expense | $654K | +65.2% |
| Operating Income | -$3.9M | -56.6% |
| Pre-tax Income | -$4.0M | -20.3% |
| Net Income | -$4.0M | -20.3% |
| EPS (Basic) | -$0.50 | -6.4% |
| EPS (Diluted) | -$0.50 | -6.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | +1705.8% |
| Accounts Receivable | $17K | — |
| Current Assets | $4.8M | +1722.4% |
| Total Assets | $5.1M | +1129.0% |
| Current Liabilities | $335K | +409.0% |
| Total Liabilities | $335K | +409.0% |
| Stockholders' Equity | $4.8M | +1264.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | -49.8% |
| Capital Expenditures | $11K | +39.2% |
| Investing Cash Flow | -$212K | -20.1% |
| Financing Cash Flow | $8.1M | +405.3% |
| Free Cash Flow | -$3.5M | -49.8% |